Ramanan , AV., Quartier , P., Okamoto , N., Foeldvari, I., Spindler, A., Fingerhutová , Š., Antón, J., Wang, Z., Meszaros, G., Araújo, J., Liao, R., Keller, S., Brunner, HI., Ruperto, N. & JUVE-BASIS investigators (2023).
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind placebo-controlled, withdrawal, efficacy, and safety trial.
Lancet,
402(10401), 555-570.
https://doi.org/10.1016/S0140-6736(23)00921-2Rasmussen, L. D., Williams, M. C., Newby, D. E.
, Dahl, J. N., Schmidt, S. E.
, Bøttcher, M. & Winther, S. (2023).
External validation of novel clinical likelihood models to predict obstructive coronary artery disease and prognosis.
Open Heart,
10(2), Article e002457.
https://doi.org/10.1136/openhrt-2023-002457,
https://doi.org/10.1136/openhrt-2023-002457
Lazarus, J. V., Mark, H. E., Allen, A. M., Arab, J. P., Carrieri, P., Noureddin, M., Alazawi, W., Alkhouri, N., Alqahtani, S. A., Arrese, M., Bataller, R., Berg, T., Brennan, P. N., Burra, P., Castro-Narro, G. E., Cortez-Pinto, H., Cusi, K., Dedes, N., Duseja, A. ... Healthy Livers, Healthy Lives Collaborators (2023).
A global research priority agenda to advance public health responses to fatty liver disease.
Journal of Hepatology,
79(3), 618-634.
https://doi.org/10.1016/j.jhep.2023.04.035Kronborg, T. M., Schierwagen, R., Trošt, K., Gao, Q., Moritz, T., Bendtsen, F.
, Gantzel, R. H., Andersen, M. L., Teisner, A. S.
, Grønbæk, H., Hobolth, L., Møller, S., Trebicka, J. & Kimer, N. (2023).
Atorvastatin for patients with cirrhosis: A randomized, placebo-controlled trial.
Hepatology Communications,
7(12), Article e0332.
https://doi.org/10.1097/HC9.0000000000000332Hessain, D.
, Dalsgaard, E. M., Norman, K., Sandbæk, A. & Andersen, A. (2023).
Oral health and type 2 diabetes in a socioeconomic perspective.
Primary Care Diabetes,
17(5), 466-472.
https://doi.org/10.1016/j.pcd.2023.07.001Gossili, F., Mogensen, A. W., Konnerup, T. C.
, Bouchelouche, K., Alberts, I., Afshar-Oromieh, A. & Zacho, H. D. (2023).
The diagnostic accuracy of radiolabeled PSMA-ligand PET for tumour staging in newly diagnosed prostate cancer patients compared to histopathology: a systematic review and meta-analysis.
European Journal of Nuclear Medicine and Molecular Imaging,
51(1), 281-294.
https://doi.org/10.1007/s00259-023-06392-0